Copyright
©2013 Baishideng Publishing Group Co.
World J Hematol. Nov 6, 2013; 2(4): 109-114
Published online Nov 6, 2013. doi: 10.5315/wjh.v2.i4.109
Published online Nov 6, 2013. doi: 10.5315/wjh.v2.i4.109
Table 1 ABO, Rh and other phenotype frequencies in Yansi population and control subjects n (%)
Yansin = 256 | Controln = 269 | P value | |
ABO phenotype | 0.19 | ||
A | 61 (23.8) | 74 (27.5) | |
B | 31 (12.1) | 38 (14.1) | |
O | 160 (62.5) | 147 (54.7) | |
AB | 4 (1.6) | 10 (3.7) | |
Rh phenotype | 0.27 | ||
ccD.ee | 183 (71.5) | 190 (70.6) | |
ccD.Ee | 31 (12.1) | 42 (15.6) | |
ccD.EE | 0 | 3 (1.1) | |
CcD.ee | 31 (12.1) | 22 (8.2) | |
CcD.Ee | 3 (1.2) | 1 (0.4) | |
CCD.ee | 1 (0.4) | 1 (0.4) | |
ccddee | 7 (2.7) | 10 (3.7) | |
Kell phenotype | |||
K+k- | 0 | 0 | |
K+k+ | 0 | 0 | |
K-k+ | 256 (100) | 269 (100) | |
Duffy phenotype | |||
Fy (a+b+) | 0 | 0 | |
Fy (a-b+) | 0 | 0 | |
Fy (a+b-) | 0 | 0 | |
Fy (a-b-) | 256 (100) | 269 (100) | |
Kidd phenotype | 0.096 | ||
Jk (a+b+) | 96 (37.5) | 81 (30.1) | |
Jk (a+b-) | 141 (55.1) | 173 (64.3) | |
Jk (a-b+) | 19 (7.4) | 15 (5.6) | |
MN phenotype | 0.0021 | ||
MM | 94 (36.7) | 124 (46.1) | |
MN | 123 (48.1) | 89 (33.1) | |
NN | 39 (15.2) | 56 (20.8) | |
Ss phenotype | 0.0006 | ||
SS | 10 (3.9) | 35 (13.0) | |
Ss | 39 (15.2) | 38 (14.1) | |
ss | 204 (79.7) | 187 (69.5) | |
S-s- | 3 (1.2) | 9 (3.4) |
Table 2 Distribution of glucose-6-phosphate dehydrogenase and hemoglobin phenotype in Yansi population and control subjects n (%)
Yansin = 256 | Controln = 269 | P value | |
G6PD | 0.74 | ||
Normal | 226 (88.3) | 235 (87.4) | |
Deficient | 30 (11.7) | 34 (12.3) | |
Hemoglobin | 0.24 | ||
AA | 200 (78.1) | 221 (82.2) | |
AS | 56 (21.9) | 48 (17.8) |
Table 3 Distribution of glucose-6-phosphate dehydrogenase deficiency in relation to gender in Yansi population and control subjects n (%)
Population | Male | Female | P value |
Yansi (n = 256) | 0.83 | ||
G6PD normal | 101 (44.7) | 125 (55.3) | |
G6PD deficient | 14 (46.7) | 16 (53.3) | |
Control (n = 269) | 0.023 | ||
G6PD normal | 117 (49.8) | 118 (50.2) | |
G6PD deficient | 24 (70.6) | 10 (29.4) |
Table 4 Clinical disorders observed in the two populations n (%)
Clinical disorders | Yansin = 256 | Controln = 269 | P value |
M = 115; W = 141 | M = 141; W = 128 | ||
Asthma | 8 (3.1) | - | - |
Rheumatism | 20 (7.8) | - | - |
Paralysis | 2 (0.8) | - | - |
Sterility | 1 (1.4) | - | - |
Sexual impotence | 1 (0.4) | - | - |
Epilepsy | 13 (5.1) | - | - |
Deafness | 1 (0.4) | - | - |
Miscarriage | 46 (32.6)1 | 3 (2.3)1 | < 0.0001 |
Stilbirth | 4 (2.8)1 | - | - |
Death in young age | 62 (24.2) | 3 (2.3) | < 0.0001 |
- Citation: Mavanga NM, Boemer F, Seidel L, Malafu AN, Gothot A, Gerard C. Blood groups, hemoglobin phenotypes and clinical disorders of consanguineous Yansi population. World J Hematol 2013; 2(4): 109-114
- URL: https://www.wjgnet.com/2218-6204/full/v2/i4/109.htm
- DOI: https://dx.doi.org/10.5315/wjh.v2.i4.109